ATE260115T1 - Reduzierte fett-absorption durch anti-lipase antikörper - Google Patents

Reduzierte fett-absorption durch anti-lipase antikörper

Info

Publication number
ATE260115T1
ATE260115T1 AT98932392T AT98932392T ATE260115T1 AT E260115 T1 ATE260115 T1 AT E260115T1 AT 98932392 T AT98932392 T AT 98932392T AT 98932392 T AT98932392 T AT 98932392T AT E260115 T1 ATE260115 T1 AT E260115T1
Authority
AT
Austria
Prior art keywords
fat absorption
reduced fat
lipase antibodies
lipase
antibodies
Prior art date
Application number
AT98932392T
Other languages
English (en)
Inventor
Julio L Pimentel
Original Assignee
Ximed Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ximed Group Plc filed Critical Ximed Group Plc
Application granted granted Critical
Publication of ATE260115T1 publication Critical patent/ATE260115T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98932392T 1997-07-07 1998-07-06 Reduzierte fett-absorption durch anti-lipase antikörper ATE260115T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/888,202 US7344713B1 (en) 1997-07-07 1997-07-07 Decreased fat absorption with an anti-lipase antibody
PCT/GB1998/001998 WO1999002187A2 (en) 1997-07-07 1998-07-06 Decreased fat absorption with an anti-lipase antibody

Publications (1)

Publication Number Publication Date
ATE260115T1 true ATE260115T1 (de) 2004-03-15

Family

ID=25392734

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98932392T ATE260115T1 (de) 1997-07-07 1998-07-06 Reduzierte fett-absorption durch anti-lipase antikörper

Country Status (14)

Country Link
US (1) US7344713B1 (de)
EP (1) EP1001809B1 (de)
JP (1) JP2001525314A (de)
CN (1) CN1269728A (de)
AT (1) ATE260115T1 (de)
AU (1) AU8232698A (de)
BG (1) BG104061A (de)
BR (1) BR9815504A (de)
CA (1) CA2295735A1 (de)
DE (1) DE69821946D1 (de)
HU (1) HUP0002753A2 (de)
IL (1) IL133881A0 (de)
TR (1) TR200000002T2 (de)
WO (1) WO1999002187A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7618624B1 (en) * 1999-01-07 2009-11-17 Anitox Corporation Weight control using an anti-lipase antibody
US20040018197A1 (en) * 2002-04-26 2004-01-29 Promega Corporation Treatment for weight loss
GB2389362B (en) * 2002-06-05 2006-02-15 Walcom Animal Science Antibodies to adipose tissues
TW200507861A (en) * 2003-04-10 2005-03-01 Ghen Corp Antiobesity agent using hen-egg antibody against digestive enzyme
WO2008013455A1 (en) * 2006-07-27 2008-01-31 Lactive B.V. Means and methods for preventing elevated blood glucose levels in humans with animal antibodies produced in milk
JP6778488B2 (ja) * 2013-12-02 2020-11-04 オーストリッチファーマ株式会社 消化酵素抗体およびそれを有する卵と卵を原料とする加工品および抗体を含む組成物と製造方法
US10538593B2 (en) 2013-12-02 2020-01-21 Ostrich Pharma Kk Method for manufacturing digestive enzyme antibody and egg having same, and for manufacturing processed product containing egg as ingredient thereof and composition including antibody
JP6872841B2 (ja) * 2014-04-28 2021-05-19 アサマ化成株式会社 脂肪低減組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
DE3689717T2 (de) * 1985-11-25 1994-10-20 Gen Corp Kk Einen spezifischen Antikörper enthaltender Stoff aus Eiern, Verfahren zu dessen Herstellung und seine Anwendung.
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
JPH0745520B2 (ja) * 1988-08-31 1995-05-17 国際試薬株式会社 モノクローナル抗体およびその使用法
US5753228A (en) * 1992-08-25 1998-05-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies
US5585098A (en) * 1993-11-23 1996-12-17 Ovimmune, Inc. Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants

Also Published As

Publication number Publication date
WO1999002187A2 (en) 1999-01-21
EP1001809A1 (de) 2000-05-24
CN1269728A (zh) 2000-10-11
AU8232698A (en) 1999-02-08
CA2295735A1 (en) 1999-01-21
IL133881A0 (en) 2001-04-30
BR9815504A (pt) 2000-11-28
DE69821946D1 (de) 2004-04-01
BG104061A (en) 2000-11-30
WO1999002187A3 (en) 2001-06-07
JP2001525314A (ja) 2001-12-11
EP1001809B1 (de) 2004-02-25
TR200000002T2 (tr) 2000-09-21
US7344713B1 (en) 2008-03-18
HUP0002753A2 (hu) 2000-12-28

Similar Documents

Publication Publication Date Title
CA2198958A1 (en) Method for amplification of the response signal in a sandwich immunoassay
BR9404242A (pt) Processo para a determinação de proteína e creatinina
ATE315228T1 (de) Immunoassay zum bestimmen von bnp
WO2000031237A3 (en) Method of cloning porcine animals
NZ331299A (en) Antibody variants with reduced affinity for a cell-surface antigen
TR200101703T2 (tr) Aktif limfotoksin-ß reseptör imunoglobülin şimerik proteinlerinin yüksek düzey ifadesi ve saflaştırılması için bir yöntem.
ES2124215T3 (es) Unos anticuerpos monoclonales al fiv y polipeptidos relacionados y su metodo de obtencion.
BR9710450A (pt) Anticorpo passivamente administrado que intensifica a eficiencia de conversÆo de alimenta-Æo
GB9613207D0 (en) Method for quantitative measurement of an enzyme linked immunosorbent assay
ATE260115T1 (de) Reduzierte fett-absorption durch anti-lipase antikörper
KR850002385A (ko) PIVKA-Ⅱ의 측정(assay)용 방법 및 시약
FI971883A (fi) Vasta-aineluokkapesifinen häiriöitä estävä reagenssi
EP1072888A3 (de) Immunoassay-Verfahren und -Reagens für HIV-1p24-Antigen
DE69818388D1 (en) Immunoassay für spongiforme encephalopathien
AU2707597A (en) Method of assay
PT733903E (pt) Processo de dosagem imunologica de cortisol nomeadamente urinario e reagentes utilizados
PT672756E (pt) Anticorpo monoclonal que reconhece a proteina de ligacao a fk506 processo de doseamento do nivel de proteina de ligaca a fk506 e "kit" para doseamento
EP0878551A3 (de) Erhöhung der FVII Empfindlichkeit eines Thromboplastinreagenzes
WO1999024835A3 (en) An immunoassay for procollagen-iii-c-terminal propeptide
ES8606500A1 (es) Un metodo para determinar la presencia de ige especifica en sueros humanos
PT901632E (pt) Processo citofluorometrico para a determinacao no soro de anticorpos contra antigenios tumorais
EA199800028A1 (ru) Винилсульфоксиды и способы их синтеза
CA2110019A1 (en) Immunoassays for determining vitamin b12, and reagents and kits therefor
TR199801514A2 (xx) N-Piruvil-L-Prolin �retimi i�in y�ntem.
DE69727975D1 (de) 5-hydroxytryptophol (5-htol) derivate, antikörper, immunoassays und detektion von kürzfristigem alkoholkonsum

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties